Showing results (101-110 of 132) with videos related to
Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptorShigeyuki Chaki, Shiho Hirota, Takeo Funakoshi, et al.The International Journal of Neuropsychopharmacology|June 13, 2018
No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation ModelLijia Chang, Hidetoh Toki, Youge Qu, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 13, 2020
Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulationKenichi Fukumoto, Manoela V Fogaça, Rong-Jian Liu, et al.Journal of Neurochemistry|February 1, 2003
Polyamine transport, accumulation, and release in brainTakashi Masuko, Kuniko Kusama-Eguchi, Kaori Sakata, et al.The International Journal of Neuropsychopharmacology|September 17, 2021
Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in RodentsMai Watanabe, Brian Marcy, Ayano Hiroki, et al.Life Sciences|July 20, 2002
In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychoticTakeo Funakoshi, Shigeyuki Chaki, Naoya Kawashima, et al.Journal of Psychiatric Research|June 11, 2020
Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled studyMakoto Kamiya, Helene D Sabia, Julie Marella, et al.European Journal of Pharmacology|February 6, 2004
Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450Shigeyuki Chaki, Atsuro Nakazato, Ludo Kennis, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2017
High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699Kazumi Koga, Yuji Nagai, Masayuki Hanyu, et al.Pharmacology, Biochemistry, and Behavior|June 13, 2006
In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonistSayoko Suetake-Koga, Toshiharu Shimazaki, Kazuaki Takamori, et al.Pageof 14